Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

Clinical trial NCT07119970 · RECRUITING

Trial details

NCT number: NCT07119970
Sponsor: University Hospital, Bordeaux
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm Myeloproliferative Disorders

Start date: 2025-12-09
Primary completion: 2028-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.